BioCentury
ARTICLE | Finance

Tending the stable

HBM BioVentures holding off on new investments, focusing on existing portfolio

June 11, 2012 7:00 AM UTC

HBM BioVentures (SIX:HBMN) won't be making new investments this fiscal year, CEO Andreas Wicki told BioCentury. Indeed, the firm's last new investment was in June 2011.

Instead, the firm will tend to its portfolio of 25 private and public companies. "We are focusing on our winners, making sure that our most promising companies are fed well," Wicki said...